BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seymour CB, Mothersill C. Breast cancer causes and treatment: where are we going wrong? Breast Cancer (Dove Med Press) 2013;5:111-9. [PMID: 24648764 DOI: 10.2147/BCTT.S44399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Nosrati N, Bakovic M, Paliyath G. Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds. Int J Mol Sci 2017;18:E2050. [PMID: 28946660 DOI: 10.3390/ijms18102050] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 9.6] [Reference Citation Analysis]
2 Suba Z. Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery. Recent Pat Anticancer Drug Discov 2016;11:254-66. [PMID: 27087654 DOI: 10.2174/1574892811666160415160211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Bizzarri M, Cucina A. SMT and TOFT: Why and How They are Opposite and Incompatible Paradigms. Acta Biotheor 2016;64:221-39. [PMID: 27283400 DOI: 10.1007/s10441-016-9281-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
4 Suba Z. The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance. Drug Des Devel Ther 2015;9:4341-53. [PMID: 26273195 DOI: 10.2147/DDDT.S89536] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
5 Suba Z. DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers. Drug Des Devel Ther 2015;9:2663-75. [PMID: 26028963 DOI: 10.2147/DDDT.S84437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]